Newsfeeds - Spark Newswire

3 minute read

Mid-Day Market Update: Dow Tumbles Over 100 Points; Ascendis Pharma Shares Spike Higher

Today, 3:27 PM

Midway through trading Thursday, the Dow traded down 0.33% to 35,288.79 while the NASDAQ fell 0.62% to 14,948.24. The S&P also fell, dropping 0.53% to 4,472.56.

ADTX

2 minute read

4 Stocks Insiders Are Buying

By Lisa Levin

Today, 3:27 PM

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

BMEA

5 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:27 PM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently reported partial exercise of underwriter’s over-allotment option.

ABSI

1 minute read

News

Rafael Holdings CEO Jonas Howard Buys 112,561 Shares At Average Price Of $44.92

By Benzinga Newsdesk

Today, 3:27 PM

-Form4 Filing

RFL

1 minute read

Rafael Starts Mid-Stage Biliary Tract Cancer Trial With CPI-613 Combo Regime

By Vandana Singh

Today, 3:27 PM

Rafael Pharmaceuticals Inc (NYSE:RFL) has completed a Phase 1b trial of CPI-613 (devimistat) combined with gemcitabine and cisplatin in patients with…

RFL

1 minute read

FDA
News

Rafael Pharma Reports Successful Completion Of Phase 1b Trial, Begins Phase 2 Trial For CPI-613 In Combo With Gemcitabine, Cisplatin In Patients With Biliary Tract Cancer

By Benzinga Newsdesk

Today, 3:27 PM

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the successful completion of a Phase 1b clinical

RFL

5 minute read

58 Biggest Movers From Friday

By Lisa Levin

Today, 3:27 PM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.

AMRS

3 minute read

38 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 3:27 PM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 175% to $17.33. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.

ARAY

2 minute read

Rafael Holdings Reports $104.2M Private Placement

By Benzinga Newsdesk

Today, 3:27 PM

Rafael Holdings, Inc. (NYSE:RFL) today announced that it has entered into definitive agreements to sell securities in a private placement that is expected to result in gross proceeds to the company of $104.2

RFL

9 minute read

Stocks That Hit 52-Week Highs On Tuesday

By Benzinga Insights

Today, 3:27 PM

During Tuesday's morning session, 124 stocks hit new 52-week highs.